{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/1221_US20240024646A1.pdf"}, "page_content": "In\n\ncertain\n\nthe\n\nmicroneedle-based\n\n[0027] embodiments, drug delivery module has a substrate supporting micropro- trusions.\n\n[0028] Preferably, the substrate and microprotrusions of the microneedle-based drug delivery module are made of a bioresorbable and biodegradable material having a sufficient stiffness to withstand force applied thereto during insertion to the tissue while the microprotrusions are able to penetrate through a surface of the target site with a sufficient depth to effectively deliver the intended substance to the target site.\n\n[0029] More preferably, the substrate and microprotru- sions of the microneedle-based drug delivery module are made of PLGA with a molecular weight of about 60,000 Da and a molar ratio of lactide:glycolide at 65:35.\n\n[0030] In certain embodiments, the substrate of the microneedle-based drug delivery module has a uniform thickness of about 120 um, or a thickness which allows certain bendability while the present device can be secured. to the tissue of the target site with various curvatures.\n\n[0031] In certain embodiments, the microneedle-based drug delivery module is coated with conductive metals which delay biodegradation thereof when it is in contact with the tissue of the target site.\n\n[0032] In certain embodiments, the conductive metals coated on at least the microprotrusions of the microneedle- based drug delivery module include magnesium and tung- sten.\n\n[0033] In certain embodiments, the magnesium and tung- sten layers in the coating on either or both of the connection between the magnesium foil and the electrodes of the microneedle-based drug delivery module and the microneedle-based drug delivery module itself have a thick- ness ratio of 10:1.", "type": "Document"}}